|
1
|
Sporn MB: The war on cancer. Lancet.
347:1377–1381. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer in Germany 2009/2010. (9th).
Contributions to the Health Reporting of the Federal Republic
(Berlin). Robert Koch Institut. 2013.(In German).
|
|
3
|
Cancer. Fact Sheet 297. Geneva: World
Health Organisation. 2014.
|
|
4
|
Paoli A, Rubini A, Volek JS and Grimaldi
KA: Beyond weight loss: A review of the therapeutic uses of
very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr.
67:789–796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ornish D, Weidner G, Fair WR, Marlin R,
Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN and
Barnard RJ: Intensive lifestyle changes may affect the progression
of prostate cancer. J Urol. 174:1065–1070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berrino F, De Angelis R, Sant M, Rosso S,
Bielska-Lasota M, Coebergh JW and Santaquilani M: Eurocare Working
group: Survival for eight major cancers and all cancers combined
for European adults diagnosed in 1995–99: Results of the EUROCARE-4
study. Lancet Oncol. 8:773–783. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Angelis R, Sant M, Coleman MP,
Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H,
Ardanaz E, et al: EUROCARE-5 Working Group: Cancer survival in
Europe 1999–2007 by country and age: Results of EUROCARE-5 - a
population-based study. Lancet Oncol. 15:23–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hölzel D and Engel J: We cannot neglect
experiences from clinical practice. The example of metastasising
colon tumour shows how clinical registers can help contribute to
the evaluation of benefits of medications. Dtsch Arztebl.
109:A424–A425. 2012.(In German).
|
|
9
|
Schlesinger-Raab A, Eckel R, Engel J,
Sauer H, Löhrs U, Molls M and Hölzel D: Metastasising breast
cancer: No prolongation of life since 20 years. Dtsch Arztebl.
102:A2706–A2714. 2005.(In German).
|
|
10
|
Gray L, Lee IM, Sesso HD and Batty GD:
Association of body mass index in early adulthood and middle age
with future site-specific cancer mortality: The Harvard Alumni
Health Study. Ann Oncol. 23:754–759. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ford ES, Bergmann MM, Kröger J,
Schienkiewitz A, Weikert C and Boeing H: Healthy living is the best
revenge: Findings from the European Prospective Investigation Into
Cancer and Nutrition - Potsdam study. Arch Intern Med.
169:1355–1362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gonzalez CA and Riboli E: Diet and cancer
prevention: Contributions from the European Prospective
Investigation into Cancer and Nutrition (EPIC) study. Eur J Cancer.
46:2555–2562. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Donaldson MS: Nutrition and cancer: A
review of the evidence for an anti-cancer diet. Nutrit J.
20:192004.
|
|
14
|
Bao Y, Han J, Hu FB, Giovannucci EL,
Stampfer MJ, Willett WC and Fuchs CS: Association of nut
consumption with total and cause-specific mortality. N Engl J Med.
369:2001–2011. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruskin DN and Masino SA: The nervous
system and metabolic dysregulation: Emerging evidence converges on
ketogenic diet therapy. Front Neurosci. 6:332012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fontana L and Klein S: Aging, adiposity,
and calorie restriction. JAMA. 297:986–994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Henderson ST: High carbohydrate diets and
Alzheimer's disease. Med Hypotheses. 62:689–700. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eaton SB and Konner M: Paleolithic
nutrition: A consideration of its nature and current implications.
N Engl J Med. 312:283–289. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mellberg C, Sandberg S, Ryberg M, Eriksson
M, Brage S, Larsson C, Olsson T and Lindahl B: Long-term effects of
a papaeolithic-type diet in obese postmenopausal women: A 2-year
randomized trail. Eur J Clin Nutr. 68:350–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Warburg O, Posener K and Negelein E: On
tumour metabolism. Biochem Z. 152:319–344. 1924.(In German).
|
|
21
|
Zhivotovsky B and Orrenius S: The Warburg
Effect returns to the cancer stage. Semin Cancer Biol. 19:1–3.
2009.(Editorial). View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Van der Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garber K: Energy boost: The Warburg effect
returns in a new theory of cancer. J Natl Cancer Inst.
96:1805–1806. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Romano AH and Conway T: Evolution of
carbohydrate metabolic pathways. Res Microbiol. 147:448–455. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Newington JT, Pitts A, Chien A, Arseneault
R, Schubert D and Cumming RC: Amyloid β resistance in nerve cell
lines is mediated by the Warburg effect. PLoS One. 6:e191912011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gogvadze V, Zhivotovsky B and Orrenius S:
The Warburg effect and mitochondrial stability in cancer cells. Mol
Aspects Med. 31:60–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weinhouse S: The Warburg hypothesis fifty
years later. Z Krebsforsch Klin Onkol. 87:115–126. 1976. View Article : Google Scholar
|
|
28
|
Holm E and Kämmerer U: Fat and
carbohydrates in diets for tumour patients. Aktuel Ernahrungsmed.
36:286–298. 2011.(In German). View Article : Google Scholar
|
|
29
|
Klement RJ and Kämmerer U: Is there a role
for carbohydrate restriction in the treatment and prevention of
cancer? Nutr Metab (Lond). 8:752011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Otto C, Klingelhöffer C, Biggemann L,
Melkus G, Mörchel P, Jürgens C, Gahn S and Kämmerer U: Experimental
studies on the metabolism of keton bodies and lactate by tumour
cells of the gastrointestinal duct. Aktuel Ernahrungsmed. 39:51–59.
2014.(In German).
|
|
31
|
Vaughn AE and Deshmukh M: Glucose
metabolism inhibits apoptosis in neurons and cancer cells by redox
inactivation of cytochrome c. Nat Cell Biol. 10:1477–1483. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gunter MJ, Hoover DR, Yu H,
Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X,
Anderson GL, et al: Insulin, insulin-like growth factor-I, and risk
of breast cancer in postmenopausal women. J Natl Cancer Inst.
101:48–60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schmidt M, Pfetzer N, Schwab M, Strauss I
and Kämmerer U: Effects of a ketogenic diet on the quality of life
in 16 patients with advanced cancer: A pilot trial. Nutr Metab
(Lond). 8:542011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kämmerer U: Ketogenic diet for cancer
patients. Würzburg, Germany: The University Hospital Würzburg.
2010.(In German).
|
|
35
|
Coy JF and Franz M: The new anti-cancer
diet: How you can stop the cancer gene. 1:(1st). Munich: Gräfe und
Unzer. 2009.
|
|
36
|
Coy JF, Dressler D, Wilde J and Schubert
P: Mutations in the transketolase-like gene TKTL1: Clinical
implications for neurodegenerative diseases, diabetes and cancer.
Clin Lab. 51:257–273. 2005.PubMed/NCBI
|
|
37
|
Langbein S, Zerilli M, Zur Hausen A,
Staiger W, Rensch-Boschert K, Lukan N, Popa J, Ternullo MP,
Steidler A, Weiss C, et al: Expression of transketolase TKTL1
predicts colon and urothelial cancer patient survival: Warburg
effect reinterpreted. Br J Cancer. 94:578–585. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun W, Liu Y, Glazer CA, Shao C, Bhan S,
Demokan S, Zhao M, Rudek MA, Ha PK and Califano JA: TKTL1 is
activated by promoter hypomethylation and contributes to head and
neck squamous cell carcinoma carcinogenesis through increased
aerobic glycolysis and HIF1α stabilization. Clin Cancer Res.
16:857–866. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schwaab J, Horisberger K, Ströbel P, Bohn
B, Gencer D, Kähler G, Kienle P, Post S, Wenz F, Hofmann WK, et al:
Expression of Transketolase like gene 1 (TKTL1) predicts
disease-free survival in patients with locally advanced rectal
cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer.
11:3632011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang S, Yang JH, Guo CK and Cai PC: Gene
silencing of TKTL1 by RNAi inhibits cell proliferation in human
hepatoma cells. Cancer Lett. 253:108–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Grimm M, Schmitt S, Teriete P, Biegner T,
Stenzl A, Hennenlotter J, Muhs HJ, Munz A, Nadtotschi T, König K,
et al: A biomarker based detection and characterization of
carcinomas exploiting two fundamental biophysical mechanisms in
mammalian cells. BMC Cancer. 13:5692013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kayser G, Sienel W, Kubitz B, Mattern D,
Stickeler E, Passlick B, Werner M and Zur Hausen A: Poor outcome in
primary non-small cell lung cancers is predicted by transketolase
TKTL1 expression. Pathology. 43:719–724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lange C, Tisch-Rottensteiner J, Böhringer
D, Martin G, Schwartzkopff J and Auw-Haedrich C: Enhanced TKTL1
expression in malignant tumors of the ocular adnexa predicts
clinical outcome. Ophthalmology. 119:1924–1929. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Feyen O, Coy JF, Prasad V, Schierl R,
Saenger J and Baum RP: EDIM-TKTL 1 blood test: A noninvasive method
to detect upregulated glucose metabolism in patients with
malignancies. Future Oncol. 8:1349–1359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jansen N and Coy JF: Diagnostic use of
epitope detection in monocytes blood test for early detection of
colon cancer metastasis. Future Oncol. 9:605–609. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mayer A, Von Wallbrunn A and Vaupel P:
Glucose metabolism of malignant cells is not regulated by
transketolase-like (TKTL)-1. Int J Oncol. 37:265–271. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rotmann AR, Hofmann HA and Coy JF: Apo10 -
a new biomarker for early detection of disorders of cell
proliferation and solid tumours. Abstracts of XX FIGO World
Congress of Gynecology and Obstetrics. Int J Gynecol Obstet.
119(Suppl 3): S4662012. View Article : Google Scholar
|
|
48
|
Fine EJ, Segal-Isaacson CJ, Feinman RD,
Herszkopf S, Romano MC, Tomuta N, Bontempo AF, Negassa A and
Sparano JA: Targeting insulin inhibition as a metabolic therapy in
advanced cancer: A pilot safety and feasibility dietary trial in 10
patients. Nutrition. 28:1028–1035. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wanka C, Steinbach JP and Rieger J:
Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects
glioma cells from starvation-induced cell death by up-regulating
respiration an dimproving cellular redox homeostasis. J Biol Chem.
287:33436–33446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rieger J, Bähr O, Maurer GD, Hattingen E,
Franz K, Brucker D, Walenta S, Kämmerer U, Coy JF, Weller M and
Steinbach JP: ERGO: A pilot study of ketogenic diet in recurrent
glioblastoma. Int J Oncol. 44:1843–1852. 2014.PubMed/NCBI
|
|
51
|
Guethlin C, Walach H, Naumann J, Bartsch
HH and Rostock M: Characteristics of cancer patients using
homeopathy compared with those in conventional care: A
cross-sectional study. Ann Oncol. 21:1094–1099. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Segar J: Complementary and alternative
medicine: Exploring the gap between evidence and usage. Health
Lond. 16:366–381. 2012.
|
|
53
|
Walach H: Spiritual and alternative cancer
therapies: Strange theories, perhaps wrong, but useful. Breast Care
(Basel). 2:190–192. 2007. View Article : Google Scholar
|
|
54
|
Chvetzoff G and Tannock IF: Placebo
effects in oncology. J Natl Cancer Inst. 95:19–29. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Walach H: Placebo effects in Complementary
and Alternative Medicine: The selfhealing response. Placebo and
Pain: From Bench to Bedside (Amsterdam). Elsevier-Academic Press.
189–202. 2013. View Article : Google Scholar
|
|
56
|
Walach H: Placebo controls: Historical,
methodological and general aspects. Philos Trans R Soc London B
Biol Sci. 366:1870–1878. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Fontana L, Partridge L and Longo VD:
Extending healthy life span - from yeast to humans. Science.
328:321–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Mutter J: Healthy instead of chronically
ill! The holistic path: prevention instead of treatment. Fit fürs
Leben Verlag (Weil der Stadt). 2009.(In German).
|
|
59
|
Ho V, Leung K, Hsu A, Luk B, Lai Jm Shen
SY, Minchinton AI, Waterhouse D, Bally MB, Lin W, et al: A low
carbohydrate, high protein diet slows tumor growth and prevents
cancer initiation. Cancer Res. 71:4484–4492. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Masko EM, Thomas JA, Antonelli JA, Lloyd
JC, Phillips TE, Poulton SH, Dewhirst MW, Pizzo SV and Freedland
SJ: Low-carbohydrate diets anmd prostate cancer: How low is ‘low
enough’? Cancer Prev Res (Phila). 3:1124–1131. 2010. View Article : Google Scholar : PubMed/NCBI
|
